Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC 0409-1273-32
Published July 20, 2016 · Recall initiated: June 23, 2016
Summary
FDA records drug Class II recall D-1359-2016, published July 20, 2016 and initiated June 23, 2016. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 373,850 tubes; Lot: Lot #: 52610LL, Exp. 01 OCT 2016; Lot #: 57660LL, Exp. 01 MAR 2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Crystallization: Product contains particulate identified to be crystallized active ingredient.
What to do
Voluntary: Firm initiated · Letter
Get an email if DIAZEPAM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DIAZEPAM
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide
- Lot
- Lot #: 52610LL, Exp. 01 OCT 2016; Lot #: 57660LL, Exp. 01 MAR 2017
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADiazepam Rectal Gel, 2.5 mg, TWIN PACK that Contains two pre-filled, unit-dose, rectal delivery systems withAugust 15, 2018
- FDAFUQINGSONG RELIEF CREAM (Flucinonide Ointment), packaged in 50-count individually labeled pieces Net Wt.July 20, 2016
- FDADuloxetine Delayed-Release Capsules, USP, 20 mg, 60-count bottles, Rx only, Manufactured by Apotex Inc,July 20, 2016
- FDADiazepam Injection, USP, 5 mg/mL, 10 mL, Multiple-dose Sterile Non-pyrogenic, Fliptop Vial, C-IV, Rx Only,September 4, 2013
- FDADiazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, HOSPIRA, INC. LAKE FOREST, ILJune 12, 2013
- FDADiazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, HOSPIRA, INC. LAKE FOREST, ILMay 15, 2013
Questions about this recall
Was Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC 0409-1273-32 recalled?
Yes. FDA published recall D-1359-2016 on July 20, 2016. Reported hazard: Crystallization: Product contains particulate identified to be crystallized active ingredient.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DIAZEPAM.